Filing

Ensysce Biosciences, Inc. Filed 2023-02-01 Acc 0001493152-23-003256

Documents 1

2023-02-07 8-A12G/A 8-A12G/A
2023-02-06 424B5 Prospectus
2023-02-01 4 Director bought 357,143 shares at $1.40 ($500,000)
2023-02-01 8-K Shareholder rights changed · Bylaws or fiscal year change · Regulation FD disclosure
2023-02-01 8-A12G 8-A12G
2023-01-31 8-K Delisting notice
2023-01-31 S-3 Registration Statement

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading form8-a12g.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…